Jones Financial Companies Lllp Sage Therapeutics, Inc. Transaction History
Jones Financial Companies Lllp
- $298 Billion
- Q1 2025
A detailed history of Jones Financial Companies Lllp transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 200 shares of SAGE stock, worth $1,414. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 12
1566.67%
Holding current value
$1,414
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SAGE
# of Institutions
218Shares Held
51.5MCall Options Held
220KPut Options Held
312K-
Black Rock Inc. New York, NY5.22MShares$36.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$35.9 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY4.48MShares$31.7 Million4.6% of portfolio
-
Tig Advisors, LLC New York, NY2.73MShares$19.3 Million1.36% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.09MShares$14.8 Million0.02% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $420M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...